Yigal Arnon represented Barclays in the offering PolyPid raised a $60 million in an initial public offering on Nasdaq. PolyPid Ltd. operates as a pharmaceutical company,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
